SPP2

secreted phosphoprotein 2

Basic information

Region (hg38): 2:234050679-234077134

Links

ENSG00000072080NCBI:6694OMIM:602637HGNC:11256Uniprot:Q13103AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • retinitis pigmentosa (Limited), mode of inheritance: AD
  • retinitis pigmentosa (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPP2 gene.

  • not_provided (178 variants)
  • not_specified (28 variants)
  • Retinal_dystrophy (15 variants)
  • SPP2-related_disorder (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006944.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
35
clinvar
1
clinvar
37
missense
1
clinvar
82
clinvar
11
clinvar
2
clinvar
96
nonsense
6
clinvar
6
start loss
0
frameshift
1
clinvar
3
clinvar
4
splice donor/acceptor (+/-2bp)
8
clinvar
8
Total 0 2 100 46 3

Highest pathogenic variant AF is 6.8409184e-7

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPP2protein_codingprotein_codingENST00000168148 726456
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.69e-140.002021257070401257470.000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3891361241.100.000006911398
Missense in Polyphen3531.1911.1221369
Synonymous0.006984444.10.9990.00000263362
Loss of Function-1.371812.71.415.35e-7160

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006300.000630
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001850.000185
Middle Eastern0.00005440.0000544
South Asian0.00006540.0000653
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Could coordinate an aspect of bone turnover. {ECO:0000250}.;
Pathway
Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis (Consensus)

Intolerance Scores

loftool
0.814
rvis_EVS
-0.32
rvis_percentile_EVS
31.69

Haploinsufficiency Scores

pHI
0.0358
hipred
N
hipred_score
0.123
ghis
0.421

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.00449

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Spp2
Phenotype

Gene ontology

Biological process
skeletal system development;platelet degranulation;negative regulation of endopeptidase activity;post-translational protein modification;cellular protein metabolic process;bone remodeling
Cellular component
extracellular region;endoplasmic reticulum lumen;platelet dense granule lumen;collagen-containing extracellular matrix
Molecular function
endopeptidase inhibitor activity